A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples